C30H39N5O5S
Neat
581.73
Room Temperature
176655-57-5; Ritonavir metabolite M11; UNII-65L8ALZ6FJ; Thiazol-5-ylmethyl N-((1S, 2S, 4S)-1-benzyl-2-hydroxy-4-(((2S)-3-methyl-2-(methylcarbamoylamino)butanoyl)amino)-5-phenyl-pentyl)carbamate; 65L8ALZ6FJ; 2, 4, 7, 12-Tetraazatridecan-13-oic acid, 10-hydroxy-5-(1-methylethyl)-3, 6-dioxo-8, 11-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (5S-(5R*, 8R*, 10R*, 11R*))-; 2, 7, 10, 12-Tetraazatridecanoic acid, 4-hydroxy-9-(1-methylethyl)-8, 11-dioxo-3, 6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S, 4S, 6S, 9S)-; RefChem:203279; Des(isopropylthiazolyl) Ritonavir; 1, 3-thiazol-5-ylmethyl N-[(2S, 3S, 5S)-3-hydroxy-5-[[(2S)-3-methyl-2-(methylcarbamoylamino)butanoyl]amino]-1, 6-diphenylhexan-2-yl]carbamate; SCHEMBL893901; CHEMBL3544831; DTXSID90735859; Q27263893; N-[(2S, 4S, 5S)-4-Hydroxy-1, 6-diphenyl-5-({[(1 and 3-thiazol-5-yl)methoxy]carbonyl}amino)hexan-2-yl]-N~2~-(methylcarbamoyl)-L-valinamide
1, 3-thiazol-5-ylmethyl N-[(2S, 3S, 5S)-3-hydroxy-5-[[(2S)-3-methyl-2-(methylcarbamoylamino)butanoyl]amino]-1 and 6-diphenylhexan-2-yl]carbamate
InChI=1S/C30H39N5O5S/c1-20(2)27(35-29(38)31-3)28(37)33-23(14-21-10-6-4-7-11-21)16-26(36)25(15-22-12-8-5-9-13-22)34-30(39)40-18-24-17-32-19-41-24/h4-13,17,19-20,23,25-27,36H,14-16,18H2,1-3H3,(H,33,37)(H,34,39)(H2,31,35,38)/t23-,25-,26-,27-/m0/s1